Device Trial Radar · NCT05689333
A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery
Last checked: Nov 20, 2026Latest source record: Apr 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Dec 9, 2022
Primary completion
May 7, 2024
Study completion May 7, 2024
Sponsor
- Lead sponsor
- VISTA OphthalmicsNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- CBCC Global Research
- First posted
- Jan 19, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, single-arm, non-comparative, open-label, monocular, post approval study to assess safety and device performance of the Vista Vitrectomy Probe during vitrectomy surgery.
Conditions
- Vitrectomy
Interventions
Vista Vitrectomy ProbeDevice
Vitrectomy will be performed through 27 GA Vista Ophthalmics vitrector
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of post-operative rates of retinal tearsTime frame: Month 1
6 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
CBCC Global Research Site:003
Los Angeles, California
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.